Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism

被引:40
作者
Lewis, DFV [1 ]
Dickins, M
机构
[1] Univ Surrey, Sch Biomed & Life Sci, Mol Toxicol Grp, Guildford GU2 7XH, Surrey, England
[2] GlaxoSmithKline Res & Dev Ltd, Ware, Herts, England
关键词
lipophilicity; cytochromes P450; human drug metabolism; SUBSTRATE-SPECIFICITY; ORGANIC-COMPOUNDS; CYP ENZYMES; K-M; 3A4; K(CAT)/K-M; INHIBITION; OXIDATION; QSARS;
D O I
10.1081/DMR-120018245
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
From analyses of human P450 substrates and their physicochemical properties, it is apparent that baseline lipophilicity relationships exist for over 70 substrates of eight drug-metabolizing P450 enzymes from families CYP1, CYP2, and CYP3. Equations of the general form shown below result in all cases investigated thus far: DeltaG(bind) = aDeltaG(part) + b where a is the slope of the line which can be termed the hydrophobicity factor of the enzyme active site, possibly being related to the extent of hydrophobic amino acid residues lining the heme pocket; b is the intercept on the y axis and can be regarded as the sum of nonhydrophobic interactions between enzyme and substrate; DeltaG(bind) is the free energy change for substrate binding to P450, based on the relationship DeltaG(bind) = RTln K-m where K-m where K-m is the Michaelis constant, and DeltaG(part) is the free energy change for partitioning between n-octanol and water based on the relationship DeltaG(part) = -RTln P where P is the n-octanol/water partition coefficient. These findings facilitate the analysis of P450 enzyme-substrate binding interactions and provide information about the likely hydrophobic character of human P450 active site regions. This shows that there are common interactions for certain numbers of substrates in each case composed of hydrogen bonding and pi-pi stacking, the extent of which varies from one P450 enzyme to another.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 36 条
[1]   Cytochromes P450 and metabolism of xenobiotics [J].
Anzenbacher, P ;
Anzenbacherová, E .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (5-6) :737-747
[2]   A unified theory of enzyme kinetics based upon the systematic analysis of the variations of kcat, and KM, and kcat/KM and the relevant ΔG0≠ values -: possible implications in chemotherapy and biotechnology [J].
Bauer, C ;
Osman, AM ;
Cercignani, G ;
Gialluca, N ;
Paolini, M .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (09) :1049-1055
[3]  
Creighton T.E., 1993, PROTEINS STRUCTURE M, V2nd
[4]  
de Montellano P.R. Ortiz., 1995, CYTOCHROME P450, V2nd
[5]   The role of CYP2B6 in human xenobiotic metabolism [J].
Ekins, S ;
Wrighton, SA .
DRUG METABOLISM REVIEWS, 1999, 31 (03) :719-754
[6]  
Ekins S, 1999, J PHARMACOL EXP THER, V291, P424
[7]   THE ROLE OF LIPOPHILICITY IN THE INHIBITION OF POLYMORPHIC CYTOCHROME-P450IID6 OXIDATION BY BETA-BLOCKING-AGENTS INVITRO [J].
FERRARI, S ;
LEEMANN, T ;
DAYER, P .
LIFE SCIENCES, 1991, 48 (23) :2259-2265
[8]   QSAR of P450 oxidation: On the value of comparing k(cat) and K-m with k(cat)/K-m [J].
Gao, H ;
Hansch, C .
DRUG METABOLISM REVIEWS, 1996, 28 (04) :513-526
[9]   QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF CYTOCHROME-P-450 [J].
HANSCH, C ;
ZHANG, LT .
DRUG METABOLISM REVIEWS, 1993, 25 (1-2) :1-48
[10]  
Hansch C., 1979, Substituent constants for correlation analysis in chemistry and biology